Promoting ColorBRAVE Conversations in Families

Promoting ColorBRAVE Conversations in Families: A Public Health Strategy to Advance Racial Equity

The objective of this research is to evaluate a mobile app-based intervention for parents of children in K-2nd grade designed that guides them in how to have productive conversations about race with their children. This study will recruit a national sample of parents and their K-2nd grade children. The impact of the intervention is tested using a wait-list controlled trial design. Outcomes include prosocial behaviors and indicators of emotional well-being.

Study Overview

• Status: Suspended
• Conditions: Parents; Child Development; Prosocial and Emotional Well-Being
• Intervention / Treatment: Behavioral: ColorBRAVE

• Study Type: Interventional
• Enrollment (Estimated): 1200
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Louisiana
    • New Orleans, Louisiana, United States, 70112
      • Tulane University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 5 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Residence in the US; caregiver age 18 years or older and child age 5-8 years old; ability to read and understand English

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: ColorBRAVE; The experimental group will be asked to download a multi-module mobile app designed to guide parents and caregivers in having conversations about race with their K-2nd grade children	Behavioral: ColorBRAVE; The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.
Other: Wait-list Control; The wait-list control group will be placed on the wait-list for the first 6-weeks, the period in which the experimental group will complete the intervention program. Following the 6-week wait-list period they will receive the ColorBRAVE program.	Behavioral: ColorBRAVE; The intervention is a multi-module program delivered via a mobile app for parents of children in K-2nd grade. Each module in the program will take approximately 30 minutes to complete, with lessons facilitated through interactive storytelling, videos, and games.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Racial Socialization Frequency Scale	Parents will report the frequency with which they engage in racial socialization practices with their K-2nd grade child.	0-12 months
Racial Socialization Competency Scale	Parents will report the degree of comfort, skills, and stress in engaging in different processes related to racial socialization with their K-2nd grade child.	0-12 months
Cross-race Friendships	Parents will report the race of their K-2nd grade child's 5 closest friends - the number of cross-race friendships will consist of the number of friends that are race discordant to their child.	0-12 months
Colorblind Racial Attitudes (CoBRAS) Scale	Color-blind racial attitudes among parents will be assessed using the COBRAS Scale.	0-12 months
Child Prosocial Behavior Questionnaire (CPBQ)	Parents will report on the degree to which their K-2nd grade child engages in various prosocial behaviors, including those surrounding helping, sharing, and comforting.	0-12 months
Child Bystander Response Questionnaire	Children will report the frequency with which they engage in different bystander behaviors when they see someone being treated poorly or unfairly due to their race, ethnicity, or cultural background.	0-12 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Parent Proxy Measures	Parent reports of child socio-emotional well being (e.g., positive peer relationships, depression, anxiety).	0-12 months
Prosocial Children Measure	Children (ages 5-8 years old) will be introduced to a child and told scenarios in which that child must choose other children to engage in various activities with, among a group of diverse children. Children will be asked (1) whether they liked or disliked how that child chose the children to participate in the activity with and (2) if there is anything they would like to say to that child about their choice in children.	0-12 months

Collaborators and Investigators

• Sponsor: Tulane University
• Collaborators: San Diego State University; University of Chicago; Tufts University; University of Illinois at Chicago
• Investigators: Principal Investigator: David H. Chae, ScD, MA, Tulane University

Study record dates

Study Major Dates

• Study Start (Estimated): August 1, 2026
• Primary Completion (Estimated): May 31, 2027
• Study Completion (Estimated): May 31, 2027

Study Registration Dates

• First Submitted: November 22, 2021
• First Submitted That Met QC Criteria: January 5, 2022
• First Posted (Actual): January 20, 2022

Study Record Updates

• Last Update Posted (Actual): May 27, 2026
• Last Update Submitted That Met QC Criteria: May 22, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: 1U01OD033242-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: Upon completion of key analyses, study documentation and de-identified data will be made available to the research community upon request. Data requests may be submitted to the Project Coordinator and reviewed by the study PI to determine whether there is significant scientific overlap in the research questions and analyses proposed by the outside investigator. Those who submit qualified proposals will be provided with a dataset containing only the variables requested and the associated documentation (e.g., codebooks, description of study protocols, data dictionaries) under a data sharing agreement.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No